Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon γ and lipopolysaccharide

Cancer Immunology Immunotherapy

Volumn 45, Issue 5, 1997, Pages 250-256

  Hennemann, Burkhard ^a   Beckmann, Gabriele ^a   Eichelmann, Annette ^a   Rehm, Annegret ^a   Andreesen, Reinhard ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Endotoxin; Immunotherapy; Interferon ; Lipopolysaccharides; Monocytes macrophages

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOLOGY; CELL KILLING; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MALE; MONOCYTE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; TISSUE GROWTH;

EID: 0031434098     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006671     Document Type: Article

References (29)

1. Alexander P, Evans R (1971) Endotoxin and double stranded RNA render macrophages cytotoxic. Nat New Biol 232:76
2. Andreesen R, Hennemann B (1991) Adoptive immunotherapy with autologous macrophages: current status and future perspectives. Pathobiology 59:259
3. Andreesen R, Kreutz M (1994) Differentiation of human monocytes in vitro: a model of macrophage ontogeny. In: Fusenig NE, Graf H (eds) Cell culture in pharmaceutical research. Springer, Berlin Heidelberg New York p 9
4. Andreesen R, Osterholz J, Bross KJ, Schulz A, Luckenbach GA, Löhr GW (1983) Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation. Cancer Res 43:5931
5. Andreesen R, Bross KJ, Osterholz J, Emmrich F (1986) Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens. Blood 67:1257
6. Andreesen R, Brugger W, Gadd S, Löhr GW, Atkins RC (1988) Activation of human monocyte-derived macrophages cultured on teflon: response to interferon-gamma during terminal maturation in vitro. Immunobiology 177:186
7. Andreesen R, Scheibenbogen C, Brugger W, Krause S, Meerpohl HG, Leser HG, Engler H, Löhr GW (1990) Adoptive transfer of tumorcytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res 50:7450
8. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB (1987) Expression and secretion of type B transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84:6020
9. Bartholeyns J, Lombard Y, Poindron P (1988) Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture. Anticancer Res 8:145
10. Chakraborty NG, Okino T, Stabach P, Padula SJ, Yamase H, Morse E, Shaàfi RI, Twardzik DR, Shultz LJ, Mukheri B (1991) Adoptive transfer of activated human autologous macrophages results in regression of transplanted human melanoma cells in scid mice. In Vivo 5:609
11. Engelhardt R, Mackensen A, Galanos C, Andreesen R (1990) Biogical response to intravenously administered endotoxin in patients with advanced cancer. J Biol Response Mod 9:480
12. Evans R, Alexander P (1972) Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity. Immunology 23:615
13. Eymard JC, Lopez M, Cattan A, Bouchè O, Adjizian JC, Bernard J (1996) Phase I/II trial of autologous activated macrophages in advanced colorectal cancer. Eur J Cancer 32:1905
14. Faradji A, Bohbot A, Schmitt-Goguel M, Roeslin N, Dumont S, Wiesel ML, Lallot C, Eber M, Bartholeyns J, Poindron P (1991) Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol Immunother 33:319
15. Fidler IJ (1974) Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. Cancer Res 34:1074
16. Hennemann B, Scheibenbogen C, Schümichen C, Andreesen R (1995) Intrahepatic adoptive immunotherapy with autologous tumorcytotoxic macrophages in patients with cancer. J Immunother 18:19
17. Hennemann B, Rehm A, Kottke A, Meidenbauer N, Andreesen R (1997) Adoptive immunotherapy with tumorcytotoxic macrophages derived from recombinant human granulocyte-macrophage colony-stimulating factor (RhuGM-CSF) mobilized peripheral blood monocytes. J Immunother (in press)
18. Hibbs JB, Chapman HA, Weinberg JB (1978) The macrophage as an antineoplastic surveillance cell: biological perspectives. J Reticuloendothel Soc 24:549
19. Kolb HJ, Holler E (1997) Adoptive immunotherapy with donor lymphocyte transfusions. Curr Opin Oncol 9:139
20. Lopez M, Fechtenbaum J, David B, Martinache C, Chokri M, Canepa S, De Gramont A, Louvet C, Gorin I, Mortel O (1992) Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: a pilot study. J Immunother 11:209
21. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265
22. Peters JH, Gieseler R, Thiele B, Steinbach F (1996) Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today 17:273
23. Scheibenbogen C, Andreesen R (1991) Developmental regulation of the cytokine repertoire in human macrophages: IL-1, IL-6, TNF-alpha and M-CSF. J Leukoc Biol 50:35
24. Scheibenbogen C, Moser H, Krause S, Andreesen R (1992) Interferon-induced expression of tissue factor activity during human monocyte to macrophage maturation. Haemostasis 22:173
25. Schwamberger G, Flesch I, Ferber E (1992) Characterisation and purification of a high molecular weight tumoricidal activity secreted by murine bone marrow macrophages. Int Immunol 4:253
26. Stevenson HC, Keenan AM, Woodhouse C, Ottow RI, Miller P, Steller EP, Foon KA, Abrams PG, Beman J, Larson SM (1987). Fate of IFN-gamma activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinoma. Cancer Res 47:6100
27. Takeda T, Kobayashi T, Monden T, Katsumoto Y, Ito Y, Wakasugi E, Wakasugi T, Tomita N, Shimano T, Mori T (1993) The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages. Biotherapy 7:47
28. Van Furth R (1993): Cell biology of mononuclear phagocytes. In: Van Furth R (ed) Hematopoietic growth factors and monocnuclear phagocytes. Karger, Basel, p 14
29. Wiesel ML, Faradji A, Grunebaum L, Bohbot A, Schmitt-Goguel M, Bergerat JP, Cazenave JP, Oberling F (1992) Hemostatic changes in human adoptive immunotherapy with activated blood monocytes or derived macrophages. Ann Hematol 65:75